Multiple Innate Immune Pathways Contribute to the Immunogenicity of Recombinant Adenovirus Vaccine Vectors
Elizabeth G. Rhee(Beth Israel Deaconess Medical Center), Dan H. Barouch(Beth Israel Deaconess Medical Center), Diana M. Lynch(Beth Israel Deaconess Medical Center), Nathaniel L. Simmons(Beth Israel Deaconess Medical Center), Bali Pulendran(Stanford University), Sudhir Pai Kasturi(Emory University), David R. Kaufman(Gates (United States)), Rosemary Kelley(Beth Israel Deaconess Medical Center), Sarah Clark(Beth Israel Deaconess Medical Center), Joseph N. Blattman(University of Washington), Annalena La Porte(Beth Israel Deaconess Medical Center), Philip D. Greenberg(University of Washington)
Cited by 80
Related Papers
IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
|Journal of Clinical Investigation|2017|3.9k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
|New England Journal of Medicine|1995|1.8k
DNA vaccine protection against SARS-CoV-2 in rhesus macaques
|Science|2020|1.1k